Literature DB >> 8191841

Simultaneous relapse of liver cell carcinoma and non-Hodgkin's lymphoma in the liver. Report of a case with diagnosis by ultrasonically guided fine needle aspiration biopsy.

L Cavanna1, G Civardi, F Fornari, D Vallisa, R Berte, E Buscarini, G Sbolli, C Paties, R Foroni, M Di Stasi.   

Abstract

A 50-year-old man was diagnosed with non-Hodgkin's lymphoma (NHL) in 1980; he was treated with chemotherapy and achieved complete remission. Six years later he reported upper abdominal pain. Ultrasound (US) showed a 3-cm mass in the right lobe of the liver. Needle aspiration showed hepatocellular carcinoma (HCC). The patient was treated with radical resection of the tumor. Three years later (June 1989), abdominal US showed two lesions in the right lobe of the liver. Needle aspiration and tissue core biopsy showed NHL in one lesion and HCC in the other. The lymphomatous lesion resolved after chemotherapy. The patient died 30 months later (January 1992) from a gastrointestinal hemorrhage; the NHL was in complete remission. This case of the simultaneous presence of HCC and hepatic lymphoma is, to our knowledge, the first diagnosed in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8191841

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  4 in total

1.  Simultaneous occurrence of a hepatocellular carcinoma and a hepatic non-Hodgkin's lymphoma infiltration.

Authors:  Sabine Heidecke; Dirk L Stippel; Arnulf H Hoelscher; Inga Wedemeyer; Hans-Peter Dienes; Uta Drebber
Journal:  World J Hepatol       Date:  2010-06-27

2.  Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis C: report of a case.

Authors:  Hirotada Tajiri; Keishi Sugimachi; Nao Kinjo; Masahiko Ikebe; Junko Tanaka; Kiyoshi Tanaka; Shuichi Tsukamoto; Shinsuke Mii; Eiji Kajiwara; Tatsuro Shimokama; Hidefumi Higashi
Journal:  Surg Today       Date:  2013-02-13       Impact factor: 2.549

3.  Coexistence of hepatoma with mantle cell lymphoma in a hepatitis B carrier.

Authors:  Mu-Hsien Lee; Yu-Ching Lin; Hao-Tsai Cheng; Wen-Yu Chuang; Hsin-Chih Huang; Hsiao-Wen Kao
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

4.  Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma.

Authors:  Qijun Li; Yong Dong; Yubin Pan; Honglin Tang; Da Li
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.